Page last updated: 2024-08-21

erythromycin and thiophenes

erythromycin has been researched along with thiophenes in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Adhikari, MD; Chattopadhyay, A; Goswami, S; Panda, BR; Ramesh, A	1
Becka, M; Kubitza, D; Mueck, W	1
Ariyawansa, J; Haskell, L; Moore, KT; Natarajan, J; Turner, KC; Vaidyanathan, S	1

Trials

2 trial(s) available for erythromycin and thiophenes

Article	Year
Co-administration of rivaroxaban with drugs that share its elimination pathways: pharmacokinetic effects in healthy subjects. British journal of clinical pharmacology, 2013, Volume: 76, Issue:3 Topics: Adolescent; Adult; Anticoagulants; ATP Binding Cassette Transporter, Subfamily B, Member 1; Clarithromycin; Cytochrome P-450 CYP2J2; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Enzyme Inhibitors; Erythromycin; Humans; Ketoconazole; Metabolic Clearance Rate; Midazolam; Middle Aged; Morpholines; Rivaroxaban; Substrate Specificity; Thiophenes; Young Adult	2013
An open-label study to estimate the effect of steady-state erythromycin on the pharmacokinetics, pharmacodynamics, and safety of a single dose of rivaroxaban in subjects with renal impairment and normal renal function. Journal of clinical pharmacology, 2014, Volume: 54, Issue:12 Topics: Aged; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Erythromycin; Factor Xa; Factor Xa Inhibitors; Female; Humans; Male; Middle Aged; Morpholines; Partial Thromboplastin Time; Prothrombin Time; Renal Insufficiency; Rivaroxaban; Thiophenes	2014

Article

Year

Co-administration of rivaroxaban with drugs that share its elimination pathways: pharmacokinetic effects in healthy subjects.

British journal of clinical pharmacology, 2013, Volume: 76, Issue:3

Topics: Adolescent; Adult; Anticoagulants; ATP Binding Cassette Transporter, Subfamily B, Member 1; Clarithromycin; Cytochrome P-450 CYP2J2; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Enzyme Inhibitors; Erythromycin; Humans; Ketoconazole; Metabolic Clearance Rate; Midazolam; Middle Aged; Morpholines; Rivaroxaban; Substrate Specificity; Thiophenes; Young Adult

2013

An open-label study to estimate the effect of steady-state erythromycin on the pharmacokinetics, pharmacodynamics, and safety of a single dose of rivaroxaban in subjects with renal impairment and normal renal function.

Journal of clinical pharmacology, 2014, Volume: 54, Issue:12

Topics: Aged; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Erythromycin; Factor Xa; Factor Xa Inhibitors; Female; Humans; Male; Middle Aged; Morpholines; Partial Thromboplastin Time; Prothrombin Time; Renal Insufficiency; Rivaroxaban; Thiophenes

2014

Other Studies

1 other study(ies) available for erythromycin and thiophenes

Article	Year
Membrane-directed high bactericidal activity of (gold nanoparticle)-polythiophene composite for niche applications against pathogenic bacteria. Advanced healthcare materials, 2013, Volume: 2, Issue:4 Topics: Anti-Bacterial Agents; Cell Survival; Drug Carriers; Erythromycin; Gastric Juice; Gold; Gram-Negative Bacteria; HT29 Cells; Humans; Hydrophobic and Hydrophilic Interactions; Membrane Potentials; Metal Nanoparticles; Nanocomposites; Polymers; Thiophenes	2013

Article

Year

Membrane-directed high bactericidal activity of (gold nanoparticle)-polythiophene composite for niche applications against pathogenic bacteria.

Advanced healthcare materials, 2013, Volume: 2, Issue:4

Topics: Anti-Bacterial Agents; Cell Survival; Drug Carriers; Erythromycin; Gastric Juice; Gold; Gram-Negative Bacteria; HT29 Cells; Humans; Hydrophobic and Hydrophilic Interactions; Membrane Potentials; Metal Nanoparticles; Nanocomposites; Polymers; Thiophenes

2013